Drug Therapy in the Heart Transplant Recipient-Reference-Cited by-同舟云学术

Drug Therapy in the Heart Transplant Recipient

Published:2005-01-18 Issue:2 Volume:111 Page:230-239
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Page Robert L.¹,Miller Geraldine G.¹,Lindenfeld JoAnn¹

Affiliation:

1. From the Department of Clinical Pharmacy (R.L.P.) and Division of Cardiology and Center for Women’s Health Research (J.L.), University of Colorado Health Sciences Center, Denver, Colo, and Division of Infectious Diseases (G.G.M.), Vanderbilt University, Nashville, Tenn.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference113 articles.

1. Drug Therapy in the Heart Transplant Recipient

2. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

3. Drug interactions: Proteins, pumps, and P-450s

4. Dipiro JT Spruill WJ Blouin RA Pruemer JM. Concepts in Clinical Pharmacokinetics. 3rd ed. Bethesda Md: American Society of Health-System Pharmacists; 2002.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-operative medication considerations in cardiac transplant patients;Journal of Prescribing Practice;2024-07-02

2. Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT;Transplant International;2024-06-19

3. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT;European Journal of Preventive Cardiology;2024-06-19

4. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT;EUR J HEART FAIL;2024

5. A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage;Pharmaceuticals;2024-02-25